In some people, overuse of some analgesics can lead to kidney damage

November 14, 2003

WINSTON-SALEM, N.C. - Overuse of some analgesics may lead to irreversible kidney damage in susceptible people, according to one conclusion of a national study being reported today (Nov. 14) at the American Society of Nephrology annual meeting in San Diego.

Vardaman Buckalew, M.D., a nephrologist at Wake Forest University Baptist Medical Center and a coauthor, said that heavy use of aspirin or acetaminophen is associated with a recently discovered condition known as SICK (Small, Indented and Calcified Kidneys). SICK is detected by CT scan of the kidneys of people with irreversible kidney failure.

"We conclude that heavy use of analgesics at least nine years prior to the development of ESRD [irreversible kidney failure] is associated with the anatomic changes of SICK," reported the eight-member research team of the National Analgesic Nephropathy Study.

Of those patients with SICK, 33 percent had overused analgesics preceding the start of dialysis, Buckalew said. "We're not sure why the other people got SICK."

Overall, 7 percent of the 222 dialysis patients in the National Analgesic Nephropathy Study were found to have SICK.

The study tested whether CT scans could be used as a diagnostic tool to find patients who overused analgesics. The CT scans missed 14 heavy users, and falsely identified 10 patients as heavy users who did not use analgesics heavily.

The research team concluded, "The CT scan is not a sensitive test for the identification of heavy analgesic use among [irreversible kidney failure] patients in the American population."

Buckalew said, however, "If a patient does have SICK, there is an increased likelihood of analgesic abuse."

Buckalew said that may indicate that some people are more susceptible to developing

SICK from heavy analgesic use -- defined as .3 of a kilogram (300 grams) per year. That works out to be about two doses of full-strength aspirin or extra strength acetaminophen every day for a year. (He stressed that it does not include those patients taking a dose of baby aspirin for prevention of heart attack or stroke.)

"We think just some individuals are susceptible," he said. "But there is no way yet to figure out which individuals are susceptible and which aren't."

The study, which also included the University of North Carolina School of Medicine in Chapel Hill, the University of Texas Southwestern Medical Center in Dallas and the Medical College of Ohio in Toledo, studied 222 patients who already were being treated for end-stage kidney disease, of which 52 - the largest group - were at Wake Forest. But none of these patients had diabetes or any other of the usual causes of kidney failure.

Trained personnel also questioned each patient in the study about whether they used analgesics heavily.

William L. Henrich, M.D., professor of medicine at the University of Maryland School of Medicine in Baltimore, presented the findings today.
-end-
Wake Forest University Baptist Medical Center is an academic health center including Wake Forest University School of Medicine and N.C. Baptist Hospital.

Media Contacts: Robert Conn (rconn@wfubmc.edu), Karen Richardson (rchrdsn@wfubmc.edu)) or Shannon Koontz (shkoontz@wfubmc.edu) at 336-716-4587

Wake Forest Baptist Medical Center

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.